Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 36755257)

  • 1. Genomic features and its potential implication in bone oligometastatic NSCLC.
    Liao R; Yi G; Shen L; Zhang X; Xu Z; Peng Y; Yang Z
    BMC Pulm Med; 2023 Feb; 23(1):59. PubMed ID: 36755257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.
    Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
    Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifying Oligometastatic Non-Small Cell Lung Cancer.
    Blumenthaler AN; Antonoff MB
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice.
    Singh AP; Shum E; Rajdev L; Cheng H; Goel S; Perez-Soler R; Halmos B
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT).
    Normanno N; Barberis M; De Marinis F; Gridelli C; On The Behalf Of The Aiot Expert Panel
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New discoveries in the molecular landscape of bladder cancer.
    Li R; Choi W; Ferguson Rd JE; Metcalfe MJ; Kamat AM
    F1000Res; 2016; 5():2875. PubMed ID: 28105319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC).
    Fumagalli C; Guerini-Rocco E; Barberis M
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel microRNA-182/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer.
    Zhao MN; Zhang LF; Sun Z; Qiao LH; Yang T; Ren YZ; Zhang XZ; Wu L; Qian WL; Guo QM; Xu WX; Wang XQ; Wu F; Wang L; Gu Y; Liu MF; Lou JT
    Cell Death Dis; 2023 May; 14(5):298. PubMed ID: 37127752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of cancer metastasis to the bone.
    Yu Y; Li K; Peng Y; Wu W; Chen F; Shao Z; Zhang Z
    Front Oncol; 2023; 13():1165380. PubMed ID: 37091152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of integrin family in bone metabolism and tumor bone metastasis.
    Mao L; Wang L; Xu J; Zou J
    Cell Death Discov; 2023 Apr; 9(1):119. PubMed ID: 37037822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress of bone metastases: From disease recognition to clinical practice.
    Yang W; Pan Q; Huang F; Hu H; Shao Z
    Front Oncol; 2022; 12():1105745. PubMed ID: 36761418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When Should Spinal Surgery Be Considered for Spinal Metastasis from Non-Small Cell Lung Cancer?-Propensity Score Matched Study between Surgery with Radiotherapy and Radiotherapy Alone.
    Park HY; Ha KY; Kim SI; Kim YS; Joh Y; Kim YH
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Liquid Biopsies Positive for
    Roldan Ruiz J; Fuentes Gago MG; Chinchilla Tabora LM; Gonzalez Morais I; Sayagues JM; Abad Hernández M; Cordovilla Pérez MR; Ludeña de la Cruz MD; Del Barco Morillo E; Rodriguez Gonzalez M
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation.
    Cheng D; Wang B; Wu L; Chen R; Zhao W; Fang C; Ji M
    Med Oncol; 2023 Jul; 40(9):254. PubMed ID: 37505345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in Asian populations: a systematic review and network meta-analysis.
    Chen W; Miao J; Wang Y; Xing W; Xu X; Wu R
    Front Pharmacol; 2023; 14():1212313. PubMed ID: 37484016
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research Progress in Immune Checkpoint Inhibitors Combination Therapy Applied to 
Non-small Cell Lung Cancer after EGFR Mutation-targeted Therapy Resistance].
    Li J; Yao X; Qiu L; Zhang R; Wang G
    Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):392-399. PubMed ID: 37316449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance.
    Araki T; Kanda S; Horinouchi H; Ohe Y
    Jpn J Clin Oncol; 2023 Jun; 53(7):547-561. PubMed ID: 37279591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort.
    Machado-Rugolo J; Baldavira CM; Prieto TG; Olivieri EHR; Fabro AT; Rainho CA; Castelli EC; Ribolla PEM; Ab'Saber AM; Takagaki T; Nagai MA; Capelozzi VL
    Braz J Med Biol Res; 2023; 56():e12488. PubMed ID: 37042869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
    Chamorro DF; Cardona AF; Rodríguez J; Ruiz-Patiño A; Arrieta O; Moreno-Pérez DA; Rojas L; Zatarain-Barrón ZL; Ardila DV; Viola L; Recondo G; Blaquier JB; Martín C; Raez L; Samtani S; Ordóñez-Reyes C; Garcia-Robledo JE; Corrales L; Sotelo C; Ricaurte L; Cuello M; Mejía S; Jaller E; Vargas C; Carranza H; Otero J; Archila P; Bermudez M; Gamez T; Russo A; Malapelle U; de Miguel Perez D; de Lima VCC; Freitas H; Saldahna E; Rolfo C; Rosell R;
    Target Oncol; 2023 May; 18(3):425-440. PubMed ID: 37017806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.